News Industry News FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation September 08, 2011
News Daily News ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients Caitlin E. Cox August 10, 2011
News Daily News After Gravitas Part 2: Is There a Future for Functional Platelet Testing? July 25, 2011
News Daily News Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT Caitlin E. Cox May 06, 2011
News Industry News Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis January 04, 2011